Mathematical Institute, University of Oxford, Oxford, UK.
Department of Plant Sciences, University of Cambridge, Cambridge, UK.
J R Soc Interface. 2021 Mar;18(176):20200982. doi: 10.1098/rsif.2020.0982. Epub 2021 Mar 17.
Here, we report that COVID-19 hospitalization rates follow an exponential relationship with age, doubling for every 16 years of age or equivalently increasing by 4.5% per year of life ( = 0.98). This mirrors the well-studied exponential decline of both thymus volume and T-cell production, which halve every 16 years. COVID-19 can therefore be added to the list of other diseases with this property, including those caused by methicillin-resistant , MERS-CoV, West Nile virus, and certain cancers, such as chronic myeloid leukaemia and brain cancers. In addition, the incidence of severe disease and mortality due to COVID-19 are both higher in men, consistent with the degree to which thymic involution (and the decrease in T-cell production with age) is more severe in men compared to women. Since these properties are shared with some non-contagious diseases, we hypothesized that the age dependence does not come from social-mixing patterns, i.e. that the probability of hospitalization rises exponentially, doubling every 16 years. A Bayesian analysis of daily hospitalizations, incorporating contact matrices, found that this relationship holds for every age group except for the under 20s. While older adults have fewer contacts than young adults, our analysis suggests that there is an approximate cancellation between the effects of fewer contacts for the elderly and higher infectiousness due to a higher probability of developing severe disease. Our model fitting suggests under 20s have 49-75% additional immune protection beyond that predicted by strong thymus function alone, consistent with increased juvenile cross-immunity from other viruses. We found no evidence for differences between age groups in susceptibility to infection or infectiousness to others (given disease state), i.e. the only important factor in the age dependence of hospitalization rates is the probability of hospitalization given infection. These findings suggest the existence of a T-cell exhaustion threshold, proportional to thymic output and that clonal expansion of peripheral T-cells does not affect disease risk. The strikingly simple inverse relationship between risk and thymic T-cell output adds to the evidence that thymic involution is an important factor in the decline of the immune system with age and may also be an important clue in understanding disease progression, not just for COVID-19 but other diseases as well.
在这里,我们报告 COVID-19 住院率与年龄呈指数关系,每增加 16 岁或等效地每年增加 4.5%(即 0.98),住院率就会翻倍。这与胸腺体积和 T 细胞生成的研究充分的指数下降相吻合,胸腺体积和 T 细胞生成每 16 年减半。因此,COVID-19 可以加入到具有这种特性的其他疾病之列,包括耐甲氧西林金黄色葡萄球菌、MERS-CoV、西尼罗河病毒和某些癌症,如慢性髓性白血病和脑癌。此外,COVID-19 导致的严重疾病和死亡率在男性中都更高,这与与女性相比,男性的胸腺退化(以及随年龄增长 T 细胞生成减少)更为严重的程度一致。由于这些特性与一些非传染性疾病共享,我们假设年龄依赖性不是来自社交混合模式,即住院的概率呈指数增长,每 16 年翻一番。对每日住院数据的贝叶斯分析,纳入接触矩阵,发现这种关系适用于除 20 岁以下人群之外的所有年龄段。虽然老年人的接触人数少于年轻人,但我们的分析表明,老年人接触人数较少和因发生严重疾病的概率较高而导致的传染性增加之间存在近似抵消。我们的模型拟合表明,20 岁以下人群的免疫保护作用比仅由强大的胸腺功能预测的要多出 49-75%,这与其他病毒引起的青少年交叉免疫力增加一致。我们没有发现年龄组之间在感染易感性或对他人的传染性(给定疾病状态)方面存在差异,即住院率的年龄依赖性唯一重要因素是感染后住院的概率。这些发现表明存在 T 细胞耗竭阈值,与胸腺输出成正比,外周 T 细胞的克隆扩增不会影响疾病风险。风险与胸腺 T 细胞输出之间的这种惊人简单的反比关系增加了胸腺退化是随着年龄增长免疫系统衰退的一个重要因素的证据,并且可能也是理解疾病进展的一个重要线索,不仅对于 COVID-19,而且对于其他疾病也是如此。